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The mechanisms by which activated Ras accelerates malignant transformation of normal cells are not
fully understood. Here, we characterized the role and molecular mechanism of c-catenin in regulating
the malignant phenotype of Rat2 cells induced by codon 12-mutant K-Ras (K-Ras12V). Suppression of
c-catenin signaling by K-Ras12V was an early event and played a crucial role in promoting the acquisition
of a highly metastatic phenotype of Rat2 cells. Notably, the gene encoding histone deacetylase 4 (HDAC4)
was identiﬁed as a target of c-catenin during this process. The transcription factor, lymphoid enhancer-
binding factor-1 (Lef1), was involved in the modulation of HDAC4 transcription, and disruption of this
pathway was a key event in promoting the invasion and migration of K-Ras12V-transduced Rat2 cells.
Thus, our ﬁndings extend the range of targets for the development of new drugs for the therapy of onco-
genic K-Ras-driven cancer.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Activated Ras family proteins can preferentially induce the
malignant transformation of cells, a process that is involved in
tumor initiation and progression [1]. Ectopic overexpression of
these proteins in noncancerous cells can lead to an invasive and
metastatic phenotype [2], whereas elimination of Ras function in
a nude mouse xenograft model of K-Ras-mutated colorectal
carcinoma DLD1 cells inhibits tumor growth [3]. During the malig-
nant transformation process, Ras interacts with and regulates mul-
tiple downstream effectors that mediate the pro-oncogenic activity
of Ras, such as Raf and Ral guanine nucleotide exchange factor
(RalGEF) [4,5], or negatively modulate the oncogenic properties
of Ras, such as Ras association (RalGDS/AF-6) domain family
(RASSF) members (e.g., Nore1) [6]. Despite the accumulated infor-
mation on Ras signaling mechanisms, much about Ras-mediated
molecular events associated with the malignant phenotypic
conversion of cells remains unknown.c-Catenin is a major plaque constituent of both desmosomes
and adherens junctions. Similar to b-catenin, this protein is an-
chored to the cytoplasmic tail of cadherin and to the actin cytoskel-
eton at submembrane sites via a-catenin [7]. The interactions of
cell adhesion molecules are necessary for tissue integrity. Thus,
changes in the expression of c-catenin can have both positive
and negative cell type-dependent effects on cell fates. Elevated
expression of c-catenin promotes neoplastic transformation of
rat kidney epithelial cells [8] and has oncogenic properties in
hepatocellular carcinoma [9]. In addition to cell–cell adhesive
roles, c-catenin interacts with signaling proteins and transcription
factors to induce cell growth [10]. Notably, when regulated by the
tumor suppressor, adenomatous polyposis coli (APC), c-catenin ex-
erts oncogenic activity via upregulation of c-Myc expression and
activation of T-cell factor/lymphoid enhancing factor-1 (Lef/Tcf1)
target genes [8]. In contrast, c-catenin acts as a tumor/metastasis
suppressor in mouse and human cells, an action that is dependent
on its ability to activate downstream signaling cascades [11,12]. c-
Catenin also readily induces apoptosis in etoposide-treated kerati-
nocytes via regulation of the apoptotic signaling cascade mediated
by Bcl-2 family members [13]. However, c-catenin expression is
unchanged during the transformation process induced in PC C13
rat thyroid cells in vitro by introduction of the activated Ras [14].
Although c-catenin is known to have dual functions in neoplastic
progression, its involvement in Ras-induced malignant transforma-
tion and the potential underlying mechanism is not clear.
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catenin in regulating induction of the malignant phenotype of Rat2
cells by activated K-Ras. We found that mutated K-Ras suppressed
the expression of c-catenin and transcription of histone deacetyl-
ase 4 (HDAC4), which we identiﬁed as a genetic target of the c-
catenin/Lef1 complex. These pathways play a critical role in acqui-
sition of the transformed phenotype and thus may provide targets
for the development of new therapeutic agents for cancer therapy.2. Materials and methods
2.1. Cell lines
Rat2 cells were cultured in RPMI-1640 medium supplemented
with 5% FBS, 50 lg/mL streptomycin, and 50 units/mL penicillin.
Activated K-Ras12V-expressing, transformed Rat2 stable cells
(Rat-K-Ras) were established by infecting Rat2 cells with retrovirus
encoding K-Ras12V using the Metafectene method (Biontex, Mu-
nich, Germany). The infected cells were selected by culturing with
1 lg/mL of puromycin (InvivoGen, San Diego, CA) for 10–15 d.
2.2. Ras activation
Ras-GTP, the activated form of Ras, was assessed using a Ras
activation assay kit (Upstate Biotechnology Inc., Lake Placid, NY)
according to the manufacturer’s instructions. Cells were lysed by
incubating with magnesium-containing lysis buffer (25 mM HEPES
pH 7.5, 150 mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 10% glyc-
erol, 25 mM NaF, 10 mM MgCl2, 1 mM EDTA, and protease inhibi-
tors) for 15 min at 4 C. Cell lysates containing 500 lg protein
were incubated with 30 lL of the glutathione S-transferase-Ras-
binding domain of Raf-1 (amino acids 1–149) for 2 h at 4 C. The
captured active Ras complexes were detected by Western blotting
with anti-Ras antibody.A
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Fig. 1. Changes in the protein expression of catenins and HDACs by oncogenic K-Ras in
activated K-Ras12V for 48 h. (A and B) Protein levels and distributions of catenins and HD
microscopy (B, scale bar: 50 lm). (C) Cytosolic and nuclear fractions were prepared from e
of cytosolic and nuclear fractions was determined by detecting tubulin and lamin, respe2.3. Retroviral production
The K-Ras12V cDNA (GGT to GTT mutation at codon 12), a gift
from Dr. P. Kirshmeier (Schering-Plough Research Institute), was li-
gated as a HpaI/StuI fragment into the corresponding sites of the
MFG retroviral vector. H29D virus-packaging cells were transfec-
ted with retroviral vector containing the K-Ras12V gene using
the Metafectene method (Biontex). After 48–72 h, virus-containing
supernatant was collected, 0.45 lm-ﬁlter sterilized, and trans-
ferred to Rat2 cells using 8 lg/mL Polybrene (Sigma, St. Louis,
MO) or stored in aliquots at 70 C for later use.2.4. Construction of expression vectors
The HDAC4 expression construct, pEGFP-HDAC4, was provided
by Dr. Claudio Brancolini (Università degli Studi di Udine, Italy).
Wild-type a-catenin [15] and non-ubiquitinatable S37A b-catenin
[16] were constructed as described previously. The wild-type c-
catenin was generated with the primer pair, 50-GAATTCATG-
GAGGTGATGAAC-30 (sense) and 50-CTC GAGGGCCAGCATGTGGTC-
30 (antisense). These primers contained either EcoRI or XhoI restric-
tion enzyme sites (underlined) to facilitate subcloning. The PCR
product was subcloned into the pcDNA3.1/myc-His vector (Invitro-
gen, Carlsbad, CA).2.5. Knockdown of proteins by small interference RNA (siRNA)
The siRNA oligonucleotides for c-catenin (sense, 50-UGAUG
AACCUUAUUGAACAUU-30; antisense, 50-UGUUCAAUAAGGUUCAU-
CAUU-30), Lef1 (sense, 50-GAAUUAGCGCGG AAAGAAAUU-30; anti-
sense, 50-UUUCUUUCCGCGCUAAUUCUU-30), and HDAC4 (sense,
50-CAUGGGUUUCUGCUACUUUAAUU-30; antisense, 50-UUAAAGUA
GCAGAAACCC AUGUU-30) were synthesized by Genolution Phar-
maceuticals, Inc (Seoul, Korea). A scrambled siRNA that showedMock
DAPI Merge
K-Ras
FITC DAPI Merge
Rat2 cells. Rat2 cells were infected with control retrovirus or retrovirus encoding
ACs were determined by Western blotting (A), and by immunoﬂuorescence confocal
ach cell line, and HDACs protein levels were determined byWestern blotting. Purity
ctively.
438 J.-H. Yim et al. / Biochemical and Biophysical Research Communications 436 (2013) 436–442no signiﬁcant homology to known gene sequences was used as a
negative control. Transfection of siRNAs into cells was performed
as described previously [17].
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
RT-PCR was performed as previously described [17]. The follow-
ing primer pairs were employed for conventional RT-PCR: HDAC4
(330 bp product), 50-ATGAGCTTCCAAAGCCATCC-30 (sense) and 50-
ATGTTCATGCAGCTGTGCCT-30 (antisense); Lef1 (219 bp product),
50-GCAGCTATCAACCAGATCC-30 (sense) and 50-GATGTAGGCAGC
TGTCATTC-30 (antisense); c-catenin (491 bp product), 50-GTCTCA
GGCGAGGACAGTTC-30 (sense) and 50-TCCTGGTAGAGCAGCAGG
TT-30 (antisense); K-Ras (377 bp product), 50-TGTGGTAGTTG-
GAGCTGGTG-30 (sense) and 50-CCTGAGCCTGTTTCGTGTCT-30 (anti-
sense); glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
440 bp product), 50-ATGGGAAGCTGGTCATCAAC-30 (sense) and 50-
GGATGCAGGGATGATGTTCT-30 (antisense). The ampliﬁcation sig-
nals of target genes were normalized against that of GAPDH in
the same reaction.
2.7. Western blot analysis
Western blot analysis was done as described previously [17]
using primary antibodies against HDAC1, HDAC2, HDAC9, Lef-1,
Lamin A/C and tubulin (Santa Cruz Biotechnology Inc., Santa Cruz,
CA); a-catenin, b-catenin and c-catenin (BD Transduction Labora-
tories, Franklin Lakes, NJ); K-Ras (Calbiochem, La Jolla, CA); andRat2
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Fig. 2. c-Catenin-dependent regulation of HDAC4 expression in Rat-K-Ras cells. (A) K
Transcript (top) and protein levels (middle) of K-Ras were determined by RT-PCR andWes
Ras-GTP using the GST-RBD of Raf-1 conjugated with agarose microspheres (bottom). (B
expression vector, or c-catenin expression vector for 48 h, as indicated. (B) Catenins a
HDAC4 expression were determined by double immunostaining (scale bar: 50 lm). (D) Qu
proteins among cells (n = 6, ⁄⁄p < 0.01 vs Rat2 cells, ⁄⁄⁄p < 0.001 vs Rat-K-Ras cells). (E) Rat
in the absence () or presence (+) of 100 nM c-catenin- targeting siRNA for 48 h, as indHDAC4 (Cell Signaling Technology Inc., Beverly, MA). b-Actin (Sig-
ma) was used as a loading control.2.8. Cell fractionation
Cells were lysed with hypotonic buffer (20 mM HEPES pH 7.5,
250 mM sucrose, 10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM
DTT, protease inhibitor cocktail) for 20 min on ice and homoge-
nized by 26 strokes of a Dounce glass homogenizer with a loose
pestle (Wheaton, Millville, NJ). The homogenate was centrifuged
at 13,000 rpm for 30 s at 4 C, and the supernatant was collected
(cytosol fraction). For isolation of the nuclear fraction, the remain-
ing pellet was suspended in 20 mM HEPES buffer (pH 7.9) contain-
ing 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol and
protease inhibitor cocktail, and centrifuged at 13,000 rpm for
5 min at 4 C.2.9. Immunohistochemistry
Cells were ﬁxed with 3.5% paraformaldehyde in PBS for 10 min
at room temperature, as described previously [15]. For staining,
cells were incubated for 1 h with the following primary
antibodies: anti-a-catenin, anti-b-catenin, and anti-c-catenin (BD
Transduction Laboratories); anti-HDAC1 and anti-HDAC2 (Santa
Cruz Biotechnology Inc.); anti-HDAC4 (Cell Signaling Technology
Inc.). The cells were washed with PBS and incubated with
rhodamine- or ﬂuorescein isothiocyanate-conjugated secondaryin
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Fig. 3. Involvement of Lef1 with c-catenin, but not b-catenin, in the regulation of HDAC4. (A) b-catenin protein level was determined by Western blotting using total cell
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4,6-diamidino-2-phenylindole (DAPI).
2.10. Assay for metastasis
In vitro invasion and migration assays were performed as
described previously [18]. For mobility assays, the monolayer
was scraped with a 200-ll micropipette tip to create a wound of
1–2 mm width. The area was subsequently photographed using
an inverted phase-contrast microscope at 100 magniﬁcation at
given time points after scratching (TE300, Nikon, Japan), and the
wounded area was deﬁned in each image by positioning lines cor-
responding to the original scratch.
2.11. Reporter gene assay
The transcriptional activity of the catenin-Tcf/Lef complex was
determined using a previously described reporter gene assay
[15]. Luciferase activity was measured and expressed relative to
b-galactosidase activity to normalize for transfection efﬁciency.
2.12. Statistical analysis
All data are expressed as mean ± standard error. Statistical eval-
uation was conducted using a one-way analysis of variance. A p-va-
lue <0.05 was considered signiﬁcant.
3. Results
3.1. Oncogenic K-Ras modulates expression and localization of catenin
and HDAC proteins in Rat2 cells
Transient infection of Rat2 cells with retrovirus expressing a
K-Ras12V oncogene led to a decrease in the adhesion junction pro-
teins a-catenin and c-catenin, but not b-catenin, compared to con-
trol Rat2 cells (Fig. 1A, left). Exogenous overexpression of K-Ras12V
signiﬁcantly downregulated the class II HDAC protein, HDAC4, and
conversely, upregulated the class I HDAC proteins, HDAC1 andHDAC2 (Fig. 1A, right). Quantiﬁcation analysis using ﬂuorescence
intensity conﬁrmed that c-Catenin and HDAC4 were reduced to
81 ± 6.8% (n = 7) and 56 ± 3.9% (n = 7) in K-Ras12V-treated Rat2
cells, respectively (Supplementary Fig. 1). Notably, K-Ras12V over-
expression in Rat2 cells induced b-catenin translocation from the
cytosol to the nucleus without changing total b-catenin protein le-
vel (Fig. 1B, top). An analysis of subcellular localization by immu-
noﬂuorescence staining revealed that HDAC1 and HDAC2 were
mainly distributed in the nucleus, whereas HDAC4 was localized
to the cytoplasm (Fig. 1B, bottom). We conﬁrmed the modulation
and localization of these HDACs byWestern blot analysis of subcel-
lular fractionations obtaining results that were completely consis-
tent with immunoﬂuorescence staining experiments (Fig. 1C).
These results suggest that alterations of catenins and HDACs may
play an important role in the malignant transformation of Rat2
cells by activated K-Ras.
3.2. c-Catenin regulates expression of HDAC4, but not HDAC1 and
HDAC2
Because c-catenin acts as a transcriptional co-activator through
its interaction with members of the Tcf/Lef transcription factor
family [19], we examined the effect of c-catenin on K-Ras12V-in-
duced modulation of HDACs. For this experiment, we established
Rat2 cells stably expressing K-Ras12V (Rat-K-Ras) and character-
ized this cell line by determining K-Ras transcript and protein lev-
els and analyzing mutant K-Ras activation (Fig. 2A). Ectopic
overexpression of a-catenin in Rat-K-Ras cells did not change the
expression levels of HDACs. Notably, however, we found that over-
expression of c-catenin markedly rescued the downregulation of
HDAC4 expression in Rat-K-Ras cells without affecting HDAC1 or
HDAC2 level (Fig. 2B). Consistent with the results of Western blot-
ting, HDAC4 protein restored by c-catenin overexpression was
localized in the cytosolic compartment (Fig. 2C). Quantiﬁcation
analysis using ﬂuorescence intensity conﬁrmed that HDAC4
expression by c-catenin overexpression was increased by
310 ± 9.9% (n = 6) in Rat-K-Ras cells (Fig. 2D). To better understand
the c-catenin-dependent induction of HDAC4, we examined the
440 J.-H. Yim et al. / Biochemical and Biophysical Research Communications 436 (2013) 436–442effect of loss of endogenous c-catenin function. As shown in
Fig. 2E, a c-catenin-speciﬁc siRNA effectively knocked down this
protein in c-catenin-overexpressing Rat-K-Ras cells without
changing a-catenin expression, and completely eliminated the
strong upregulation of HDAC4 protein induced by c-catenin accu-
mulation. Notably, depletion of c-catenin did not alter the levels of
HDAC9, a class II HDAC used as a negative control (Fig. 2E). Thus,
our results demonstrate that HDAC4 is selectively and positively
regulated by c-catenin, but not by a-catenin.3.3. Lef1 interacts with c-catenin, but not b-catenin, to play a role in
regulating HDAC4 transcription
We conﬁrmed the nuclear translocation of b-catenin in Rat2
cells transiently infected with K-Ras12V (see Fig. 1B) by examining
subcellular fractionations prepared from Rat-K-Ras cell line. As ex-
pected, b-catenin was reduced in the cytosolic fraction of Rat-K-
Ras cells and showed a reciprocal increase in the nuclear fraction
compared to parental Rat2 cells (Fig. 3A, bottom) without changing
total protein level (Fig. 3A, top). To examine whether b-catenin,
plays a role in the regulation of HDAC4 expression, we ectopically
expressed b-catenin in Rat-K-Ras cells. Overexpression of b-catenin
in Rat-K-Ras cells caused a signiﬁcant increase in b-catenin/Lef1
complex transcriptional activity compared to untransfected con-
trol and parental Rat2 cells (Fig. 3B, top), but it had no effect on
HDAC4 expression (Fig. 3B, bottom). To better understand the rela-
tionship between c-catenin and HDAC4 expression, we transfectedDB
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Overexpression of c-catenin effectively induced an increase in
c-catenin/Lef1 complex transcriptional activity in Rat-K-Ras cells
compared to untransfected control cells (Fig. 3C, top). This c-cate-
nin-induced increase in c-catenin/Lef1 activity was subsequently
accompanied by a restoration of HDAC4 protein levels that had
been decreased by activated K-Ras12V (Fig. 3C, bottom). Next,
using siRNA to knockdown endogenous Lef1, we examined
whether the Lef1 pathway is involved in c-catenin-mediated
HDAC4 regulation. Depletion of Lef1 in Rat-K-Ras cells caused a de-
crease in both transcript (Fig. 3D, top) and protein (Fig. 3D, bottom)
levels of HDAC4, essentially reversing the restoration of HDAC4
expression induced by c-catenin overexpression. These results
suggest that the Lef1 signaling pathway acts as a positive mediator
of c-catenin-induced HDAC4 expression.3.4. HDAC4 is essential for regulating the oncogenic K-Ras-induced
malignant phenotype of Rat2 cells
To elucidate whether HDAC4 is involved in regulating the onco-
genic K-Ras-mediated malignant phenotype of Rat2 cells, we
tested HDAC4 effects on invasion and migration status. HDAC4-
speciﬁc siRNA effectively knocked down endogenous HDAC4
expression in Rat2 cells (Fig. 4A, top). Interestingly, depletion of
HDAC4 in Rat2 cells induced a slight increase in invasion
(29 ± 3.1%, n = 3), migration (34 ± 4.5%, n = 3), and motility
(30 ± 3.6%, n = 3), compared to control Rat2 cells (Fig. 4,B and C).Vector
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cells (Fig. 4A, bottom). As expected, Rat-K-Ras cells displayed much
higher levels of invasion, migration, and motility than Rat2 cells
(data not shown). However, overexpression of HDAC4 in Rat-K-
Ras cells had a dramatic effect on the transformed phenotype,
reducing invasion, migration, and mobility by approximately
82 ± 6.3%, 54 ± 4.1%, and 66 ± 5.5% (n = 3), respectively compared
to control malignant R-K-Ras cells (Fig. 4,D and E). To examine
whether c-catenin regulates the transformed phenotype of Rat-
K-Ras cells, we ﬁrst ectopically overexpressed wild-type c-catenin
in Rat-K-Ras cells. Overexpression of c-catenin in Rat-K-Ras cells
reduced cell penetration through Matrigel-coated membranes to
low levels compared to control R-K-Ras cells, whereas siRNA-med-
iated depletion of c-catenin in the c-catenin-overexpressing Rat-
K-Ras cells restored invasion activity to its former high levels
(Fig. 4F, top). Consistent with the pattern of c-catenin modulation,
siRNA-mediated knockdown of HDAC4 also restored invasive
activity to c-catenin-overexpressing Rat-K-Ras cells (Fig. 4F,
bottom). Invading cells were increased by 250 ± 9.2% (n = 3) by c-
catenin depletion and 230 ± 8.7% (n = 3) by HDAC4 depletion in
c-catenin overexpressing Rat-K-Ras cells (Fig. 4G). Collectively,
these results suggest that c-catenin and its target HDAC4 act as
key regulators of activated K-Ras-driven malignant transformation
in Rat2 cells.
4. Discussion
Investigating prognostic markers and their signaling pathways
is critical in deﬁning the risks of individual cancer patients for
radiotherapy or chemotherapy. Identifying molecular mechanisms
that promote increased mitogenic signaling through alteration of
Ras signal transduction is especially important because Ras muta-
tions are found in approximately 30% of all human malignancies
[20]. K-Ras mutations, which are also useful biomarkers for detect-
ing colorectal cancer, have been reported to occur early in tumor-
igenesis [21]. The Ras/Raf/MEK/ERK cascade is well deﬁned as an
essential component of intracellular signaling from activated cell
surface receptors to transcription factors in the nucleus, and is
associated with tumor initiation and development [22]. However,
certain aspects of its function and the role of other signaling path-
ways in cancer development remain ill deﬁned.
Consistent with the previous demonstration that H-Ras induces
invasion and migration of breast epithelial cells [23], we also ob-
served that K-Ras activation led to an increase in invasive and
migratory properties of Rat2 ﬁbroblast cells, indicating that this
property of Ras extends to different Ras isoforms and cell lines.
During this process, activated K-Ras downregulated c-catenin
expression, a phenomenon that played a role in promoting the
malignant phenotype of Rat2 cells. How oncogenic K-Ras sup-
presses c-catenin expression is unclear and is a subject for future
study. To date, the potential role of c-catenin as oncogene or tumor
suppressor has been a matter of controversy [8,9,11,12]. Studies
examining c-catenin signaling in SCC9 cells and non-small cell
lung cancer cell lines have concluded that c-catenin acts through
inhibition of the oncogenic activity of b-catenin to function as a tu-
mor suppressor [24]. Our data also suggest that c-catenin is able to
act as a tumor suppressor in normal Rat2 cells, but the mechanism
is independent of b-catenin and instead depends on gene regula-
tion by c-catenin. Similar to b-catenin, c-catenin regulates gene
expression by binding to DNA via interaction with Tcf/Lef family
transcription factors. In fact, our results showed that exogenous
expression of c-catenin resulted in increased Tcf/Lef transcrip-
tional activity in oncogenic K-Ras-transduced Rat2 cells, although
this activity was less than that of the b-catenin-Tcf/Lef complex
(Fig. 3). Importantly, we identiﬁed the gene for the class II HDAC
family member HDAC4 as a target of c-catenin, which promotedHDAC4 transcription in a Lef1-dependent manner, suggesting that
the b-catenin/Lef1 complex is unable to promote HDAC4 gene
expression.
Transcription is controlled, in part, by the dynamic acetylation
and deacetylation of histone proteins, and HDACs are important
mediators of this latter process. The primary role of HDAC4 is to re-
press gene expression following loss of its interaction with 14-3-3
in the cytoplasm and subsequent interaction with myocyte enhan-
cer factor 2 (MEF2) in the nucleus [25]. Here, we presented evi-
dence that activated K-Ras downregulates HDAC4 expression.
This suggests the possibility that the oncogenic-K-Ras signal cas-
cade promotes malignant phenotype-related gene expression by
diminishing the function of the HDAC4 repressor, thereby inducing
cancer initiation and development. Although additional studies are
needed to identify new molecular targets of HDAC4, our gain-of-
function and loss-of-function strategies, which showed that over-
expression inhibited the malignant phenotype of Rat-K-Ras cells
and depletion induced the malignant transformation of Rat2 cells,
clearly establish the role of HDAC4 in this process.
In conclusion, c-catenin has both oncogenic and tumor suppres-
sor functions, reﬂecting its ability to activate different downstream
signaling pathways. Therefore, changes in the expression of
c-catenin can be an important factor governing cell fates, including
transformation.
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